trending Market Intelligence /marketintelligence/en/news-insights/trending/3UB2v6s7NyEFAB8QVXcE5Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Amgen negotiates extension in $2.5B credit agreement

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Amgen negotiates extension in $2.5B credit agreement

Amgen Inc. amended a 2014 credit agreement with certain financial institutions, negotiating an extension to the agreement's maturity.

The Thousand Oaks, Calif.-based biotech company's credit limit is set at $2.5 billion, and the agreement now matures in December 2024, extendable by up to two years at Amgen's request.

Amgen may also request an increase of up to $750 million in its credit limit.

Amgen plans to use the borrowings for general corporate purposes.